$LLBO Q1 sould be interesting! "The addition of OSU, which is forecast to come on stream early in the first quarter of 2016, is expected to accelerate the pace of trials as the patient population and volume is far more significant."
http://finance.yahoo.com/news/lifeline-biotec...-133000147.